| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |